Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Mark Coleman
23 Feb 2026
Director
Exercised, kept
6,250
$4.95
$30.94K
Mark Coleman
20 Feb 2026
Director
Exercised, kept
12,485
$4.95
$61.80K
Mark Coleman
10 Feb 2026
Director
Exercised, kept
5,193
$8.02
$41.65K

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 21
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 578,146
History held since 23 Nov 2015